Product peptide-synthetic-peptide

Home > products > peptide> synthetic-peptide

Catalog	name	Description	price
R-M-1700	(Ser8)-GLP-1 (7-36), amide, human,CAS :215777-46-1	This product is intended for laboratory use only, and it is not meant for human consumption.	price>
R-M-1701	Corticostatin, human	Human Cortistatin (CORT) Protein is a Recombinant Human protein expressed in E. coli.	price>
R-M-1705	Buserelin-NHNH2	Buserelin is a longer acting synthetic peptide analog of the naturally occurring gonadotropin-releasing hormone (GnRH/LHRH). Substitution of glycine in position 6 by D-serine and that of glycinamide in position 10 by ethylamide, leads to a nonapeptide with a significantly enhanced LHRH effect. The effects of buserelin on follicle-stimulating hormone (FSH) and luteinizing hormone (LH) release are approximately 20 to 170 times higher than those of natural LHRH.	price>
R-M-1708	Transdermal Peptide TD-1	Transdermal Peptide TD-1 is novel peptide designed to enhance transdermal drug delivery. Mechanistic studies suggest that the peptide creates transient opening in the skin barrier, which enables protein-sized molecules to pass through the skin and reach systemic circulation. When TD-1 is co-administrated with insulin on rat skin, systemic levels of insulin and human growth hormone are increased significantly.	price>
R-M-1710	Deslorelin High acetate salt,CAS :57773-65-6	Deslorelin is a synthetic nonapeptide analogue of the natural gonadotrophin releasing hormone (GnRH) with potential antineoplastic activity. Deslorelin binds to and activates pituitary gonadotropin releasing hormone (GnRH) receptors.	price>
R-M-1713	Transdermal Peptide TD-1 Amide	Transdermal Peptide TD-1 Amide is novel peptide designed to enhance transdermal drug delivery. Mechanistic studies suggest that the peptide creates transient opening in the skin barrier, which enables protein-sized molecules to pass through the skin and reach systemic circulation. When TD-1 is co-administrated with insulin on rat skin, systemic levels of insulin and human growth hormone are increased significantly.	price>
R-M-1714	Nafarelin,CAS:76932-56-4	Nafarelin is a synthetic decapeptide agonist of the luteinizing hormone-releasing hormone (LHRH) which is approximately 200 times more potent than the natural peptide. Like LHRH nafarelin stimulates the release of the gonadotrophins luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the anterior pituitary which in turn results in an initial increase of testosterone and estradiol synthesis. Continuous administration of LHRH or one of its analogs causes a sustained down-regulation of circulating LH and FSH levels leading to a suppression of testicular and ovarian steroidogenesis. Currently, nafarelin is indicated for the treatment of endometriosis and for the use in reproductive medicine.	price>
R-M-1717	Vasonatrin Peptide (1-27) ,CAS:141676-35-9	Chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) that possesses the venodilating actions of CNP, the natriuretic actions of ANP, and unique arterial vasodilating actions associated with neither ANP nor CNP. Its sequence contains the 22 amino acids of CNP plus the 5 C-terminal amino acids of ANP.	price>
R-M-1718	C-Type Natriuretic Peptide (32-53) (human, porcine, rat),CAS:127869-51-6	CNP-22 is a potent and selective activator of the human BNP cell surface receptor, a transmembrane guanylyl cyclase.	price>
R-M-1721	HIV gag p24 (265-280),CAS :118720-30-2	KRWIILGLNKIVRMYC, HIV gag p24 (265-280), a HLA-B37 epitope.	price>

...